中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
9期
164-165
,共2页
复合式小梁切除术%治疗%青光眼%效果
複閤式小樑切除術%治療%青光眼%效果
복합식소량절제술%치료%청광안%효과
Compound trabeculectomy%Treatment%Glaucoma%Efficacy
目的:对复合式小梁切除术治疗青光眼的临床实际效果进行分析探讨。方法选取我院于2013年6月~2014年8月收治的38例青光眼患者随机分成对照组和治疗组,对照组患者采用传统小梁切除术治疗,治疗组患者复合式小梁切除术治疗,对两组患者的治疗效果进行对照分析。结果治疗组患者的术后平均眼压、视野改善情况以及术后并发症发生情况与对照组比较有统计学意义(P<0.05)。结论复合式小梁切除术治疗青光眼有着显著的疗效,能够显著的降低眼压,明显改善患者的视野情况,并且能够大大降低术后并发症发生情况,是临床治疗青光眼的首选治疗方法,值得在临床实践中推广使用。
目的:對複閤式小樑切除術治療青光眼的臨床實際效果進行分析探討。方法選取我院于2013年6月~2014年8月收治的38例青光眼患者隨機分成對照組和治療組,對照組患者採用傳統小樑切除術治療,治療組患者複閤式小樑切除術治療,對兩組患者的治療效果進行對照分析。結果治療組患者的術後平均眼壓、視野改善情況以及術後併髮癥髮生情況與對照組比較有統計學意義(P<0.05)。結論複閤式小樑切除術治療青光眼有著顯著的療效,能夠顯著的降低眼壓,明顯改善患者的視野情況,併且能夠大大降低術後併髮癥髮生情況,是臨床治療青光眼的首選治療方法,值得在臨床實踐中推廣使用。
목적:대복합식소량절제술치료청광안적림상실제효과진행분석탐토。방법선취아원우2013년6월~2014년8월수치적38례청광안환자수궤분성대조조화치료조,대조조환자채용전통소량절제술치료,치료조환자복합식소량절제술치료,대량조환자적치료효과진행대조분석。결과치료조환자적술후평균안압、시야개선정황이급술후병발증발생정황여대조조비교유통계학의의(P<0.05)。결론복합식소량절제술치료청광안유착현저적료효,능구현저적강저안압,명현개선환자적시야정황,병차능구대대강저술후병발증발생정황,시림상치료청광안적수선치료방법,치득재림상실천중추엄사용。
Objective To explore compound trabeculectomy efficacy in treatment of glaucoma. Methods Select 38 glaucoma patients who are received and treated in hospital from June 2013 to August 2014 and separate them into control group and study group at random;patients in control group are given conservative trabeculectomy treatment,while patients in study group are given compound trabeculectomy treatment and then compare treatment efficacy of patients in these two groups. Results Patients’postoperative IOP(intraocular optical pressure),vision improvement and postoperative complication incidence in study group is quite differential from those in control group;and such a differential has statistic value(P<0.05). Conclusion Compound trabeculectomy treatment is of efficacy in treatment of glaucoma;it is conducive to decreasing patients’IOP(intraocular optical pressure),improving patients’vision and reducing postoperative complication incidence,it is the most preferred choice in clinical treatment of glaucoma,which is quite worthwhile to be promoted and applied clinical y.